[PDF][PDF] Effectiveness and safety of filgotinib in rheumatoid arthritis: a real-life multicentre experience
L La Barbera, C Rizzo, F Camarda, F Atzeni… - Clinical and …, 2024 - iris.unipa.it
L La Barbera, C Rizzo, F Camarda, F Atzeni, G Miceli, ABM Colella, V Franchina, A Giardina…
Clinical and Experimental Rheumatology, 2024•iris.unipa.it… We present herein the first real-world cohort of RA patients treated with filgotinib obtained
from a multicentre study. The co-primary objectives of the study were to assess the effectiveness
and the safety of treatment with filgotinib in our cohort of RA patients after 12 weeks. We
present data even at 24 weeks for patients that reached this timepoint in the extension study.
… Our study is the first multicentric study designed to evaluate effectiveness and safety of
filgotinib in an Italian cohort of RA patients (Table IV). Patients were arrayed according to …
from a multicentre study. The co-primary objectives of the study were to assess the effectiveness
and the safety of treatment with filgotinib in our cohort of RA patients after 12 weeks. We
present data even at 24 weeks for patients that reached this timepoint in the extension study.
… Our study is the first multicentric study designed to evaluate effectiveness and safety of
filgotinib in an Italian cohort of RA patients (Table IV). Patients were arrayed according to …
Objective
We investigated the effectiveness and safety of filgotinib in a real-life multicentre cohort of rheumatoid arthritis (RA) patients.
iris.unipa.it
以上显示的是最相近的搜索结果。 查看全部搜索结果